Powered by lexis nexis

Will more pharmas defy Trump after Merck CEO‘s council exit? Don‘t count on it

Aug 15, 2017 - FiercePharma

Merck CEO Ken Frazier made waves far beyond the pharma industry when he stepped down from President Donald Trump’s manufacturing panel Monday, taking a stand against “intolerance and extremism” in the wake of violence in Charlottesville. Where does that leave other drug executives who’ve worked with the president to push their proposals?

Big pharma companies whose CEOs have had sit-downs with Trump aren't saying much about Frazier's high-profile exit. Some biotech leaders, however...